|
In two standout sessions, experts from the NIH and the FDA led us in captivating and informative panels on days one and two, respectively.
The NIH Town Hall, featuring PJ Brooks, PhD, Jill Morris, PhD, and John Tisdale, MD, provided updates on rare disease initiatives including the Bespoke Gene Therapy Consortium.
The FDA Plenary Panel, featuring John Concato, MD, MS, MPH, Donna Rivera, PharmD, MSc, Zhenzhen Xu, PhD, Anne McMahon, MD, MS, and Felipe Aguel, PhD, focused on the importance of real-world data (RWD) and real-world evidence (RWE).
|
